A case of severe Alexander disease with de novo c. 239 T > C, p.(F80S), in GFAP

Brain Dev. 2018 Aug;40(7):587-591. doi: 10.1016/j.braindev.2018.03.002. Epub 2018 Mar 21.

Abstract

Alexander disease (AxD) is a progressive neurodegenerative disease caused by a mutation in the glial fibrillary acid protein (GFAP) gene. A 4-year-old boy presented several times with hemiclonic seizures with eye deviation for a few minutes at 28 days after birth. Electroencephalogram showed independent sharp waves in the right and left temporal area. Magnetic resonance imaging showed high intensity T1-weighted images in the white matter of the frontal lobe and basal ganglia. He showed no head control at 4 years of age, and his weight gain was insufficient. He did not show macrocephaly. At 4 years of age, he died of bacterial pneumonia and septic shock. He was diagnosed with AxD, and direct sequencing revealed a de novo known mutation, c. 239 T > C, p.(F80S), in GFAP. Hela and U2-OS cells transfected with GFAP cDNA with c. 239 T > C showed dot-like cytoplasmic aggregation, similar to R239C, a common mutation found in severe infantile AxD. Aggregation in the cytoplasm caused by a GFAP mutation is a hallmark of AxD. Although there is only one previous report of a patient with an F80S mutation, our data support that F80S can cause the severe, infantile form of AxD.

Keywords: Aggregation; Alexander disease (AxD); Glial fibrillary acid protein (GFAP).

Publication types

  • Case Reports

MeSH terms

  • Alexander Disease / diagnostic imaging
  • Alexander Disease / genetics*
  • Alexander Disease / pathology
  • Alexander Disease / physiopathology
  • Brain / diagnostic imaging
  • Cell Line, Tumor
  • Child, Preschool
  • Cytoplasm / metabolism
  • Cytoplasm / pathology
  • Fatal Outcome
  • Glial Fibrillary Acidic Protein / genetics*
  • HeLa Cells
  • Humans
  • Male
  • Mutation*
  • Transfection

Substances

  • GFAP protein, human
  • Glial Fibrillary Acidic Protein